Trials / Completed
CompletedNCT05681247
Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
Study on the Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- The Affiliated Hospital of Qingdao University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to assess the bioequivalence of the ezetimibe tablet to Ezetrol ® in healthy Chinese volunteers and estimate the pharmacokinetic profiles of ezetimibe tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ezetimibe tablet | The subjects randomly received single oral administration of ezetimibe tablet 10 mg |
| DRUG | ezetimibe tablet(Ezetrol ®) | The subjects randomly received single oral administration of ezetimibe tablet (Ezetrol ®) 10 mg. |
Timeline
- Start date
- 2017-12-17
- Primary completion
- 2018-01-29
- Completion
- 2018-03-07
- First posted
- 2023-01-12
- Last updated
- 2023-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05681247. Inclusion in this directory is not an endorsement.